Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2016-04-27 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
2016年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "2016 年第一季度报告全文" which translates to "2016 First Quarter Report Full Text." It contains detailed financial data including income, net profit, cash flow, assets, liabilities, shareholder information, and management commitments. The presence of comprehensive financial statements such as the consolidated balance sheet and detailed financial metrics for the quarter indicates this is a quarterly financial report. The document is about 15,000 characters long, which is consistent with a full interim report rather than a brief announcement or summary. There is no indication that this is an announcement of a report or a certification letter. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2016
2016-04-27 Chinese
关于第三届监事会第五次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolution passed by the Supervisory Board regarding the company's 2016 first quarter report. It states that the Supervisory Board has reviewed and approved the first quarter report, confirming its compliance and accuracy. The document itself does not contain the full first quarter report or detailed financial data, but rather the approval and assurance of the report's validity. The document length is short (680 characters), and it serves as a formal announcement of the Supervisory Board's resolution rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such announcements that do not contain the full report or detailed financial data.
2016-04-27 Chinese
2016年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled "2016 年第一季度报告正文" which translates to "2016 First Quarter Report Main Text." It contains detailed financial data for the first quarter of 2016, including revenue, net profit, cash flow, and changes in assets and liabilities. It also includes shareholder information, major shareholders' holdings, and detailed notes on important matters and commitments made by the company and its executives. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly) indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data and management discussion, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2016
2016-04-27 Chinese
关于第三届董事会第六次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution passed at the company's board meeting regarding the approval of the 2016 first quarter report. It does not contain the actual financial data or the report itself, but rather the board's approval of the report. The document length is short (647 characters), and it is a formal announcement of a board meeting decision. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2016-04-27 Chinese
关于证券事务代表辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's securities affairs representative. It includes no financial data, no report or presentation, and no voting or dividend information. It is a management-related announcement about a personnel change, specifically concerning a company officer role. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on this personnel change, confirming the classification.
2016-04-20 Chinese
关于公司及子公司营业执照、组织机构代码证、税务登记证“三证合一”和子公司经营范围等工商变更的公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from Guangdong Taicheng Pharmaceutical Co., Ltd. regarding changes to the company's and its subsidiary's business licenses and organizational codes, specifically the consolidation of three certificates into one and changes to the subsidiary's business scope and address. It is a regulatory announcement about administrative and registration changes, not a financial report, earnings release, or management discussion. The document is relatively short (1936 characters) and does not contain financial data or detailed analysis. It fits the category of a general regulatory announcement about corporate administrative changes, which aligns with the Regulatory Filings (RNS) category as a fallback for miscellaneous filings that do not fit other specific categories.
2016-04-08 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.